Ophthalmology · Tallahassee, FL
NPI
1730136904
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2020 Fleischmann Rd
Tallahassee, FL, 32308
Phone (850) 878-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$293K
2,638 services
Medicare patients, 2024
752
Average age 76
Drug cost, 2024
$2.7M
9,122 prescriptions
Company payments, 2025
$598
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Viet N Bui was code 99213 (office e&m - established), 604 times for 407 patients. In total Viet N Bui billed 2,638 services in 44 codes, and Medicare paid $293K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 604 | 407 | $65.87 | $40K |
| 99214 Office E&M - Established | Office | 467 | 387 | $85.84 | $40K |
| 92136 Ultrasound - Nonspecific | Office | 260 | 162 | $29.64 | $7,707 |
| 66984 Cataract Surgery | Facility | 234 | 132 | $387.33 | $91K |
| 92133 Computerized Ophthalmic Imaging | Office | 231 | 229 | $24.04 | $5,554 |
| 92014 Ophthalmological E&M | Office | 209 | 208 | $76.00 | $16K |
| 92083 Vision, Hearing, and Speech Services | Office | 196 | 187 | $41.29 | $8,092 |
| 99204 Office E&M - New | Office | 72 | 72 | $113.71 | $8,187 |
| 66821 Cataract Surgery | Facility | 61 | 47 | $254.11 | $16K |
| 92134 Computerized Ophthalmic Imaging | Office | 43 | 38 | $25.61 | $1,101 |
| 65855 Fluid Flow and Drainage of Eye (Any Method) | Facility | 40 | 26 | $169.69 | $6,788 |
| 65820 Fluid Flow and Drainage of Eye (Any Method) | Facility | 37 | 22 | $661.24 | $24K |
| 76514 Ultrasound - Nonspecific | Office | 33 | 33 | $8.80 | $290 |
| 92020 Ophthalmological E&M | Office | 25 | 25 | $22.53 | $563 |
| 68761 Eye | Office | 24 | 20 | $154.42 | $3,706 |
By year: 2022 $303K for 2,937 services; 2023 $283K for 2,759 services; 2024 $293K for 2,638 services.
Medicare prescription drug claims, 2024
In 2024, the drug Viet N Bui prescribed most often to Medicare patients was Latanoprost, with 1,991 prescriptions and refills. In total Viet N Bui wrote 9,122 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,991 | 3,905 | 520 | $34K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 1,151 | 2,185 | 301 | $24K |
| Brimonidine Tartrate Generic | 952 | 1,662 | 245 | $30K |
| Moxifloxacin Moxifloxacin Hcl | 653 | 654 | 464 | $19K |
| Prednisolone Acetate Generic | 620 | 719 | 352 | $20K |
| Rhopressa Netarsudil Mesylate | 576 | 785 | 121 | $254K |
| Timolol Maleate Generic | 369 | 648 | 108 | $4,384 |
| Restasis Cyclosporine | 301 | 387 | 102 | $235K |
| Lumigan Bimatoprost | 295 | 455 | 69 | $125K |
| Dorzolamide Hcl Generic | 281 | 544 | 88 | $5,942 |
| Travoprost Generic | 191 | 313 | 43 | $31K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 172 | 261 | 49 | $29K |
| Ketorolac Tromethamine Generic | 166 | 174 | 93 | $3,909 |
| Valacyclovir Valacyclovir Hcl | 132 | 196 | 26 | $6,102 |
| Simbrinza Brinzolamide/Brimonidine Tart | 112 | 149 | 27 | $26K |
Brand drugs: 3,367 claims; generic drugs: 5,755 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Viet N Bui $598 ($598 in general payments such as food, travel and fees) from 7 companies. The largest payer was Alcon Vision LLC with $273.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 12 | $273 |
| Abbvie Inc. ABBV | 6 | $180 |
| Bausch & Lomb Americas Inc. BLCO | 3 | $61.85 |
| Dompe US, Inc. | 1 | $27.09 |
| Oyster Point Pharma, Inc. | 1 | $21.11 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $18.56 |
| Thea Pharma Inc. | 1 | $16.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.